Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
暂无分享,去创建一个
Sabino Iliceto | Giuseppe Tarantini | Diego Miotto | Francesco Tona | B. Giorgi | D. Corrado | S. Iliceto | G. Thiene | C. Basso | G. Tarantini | D. Miotto | F. Tona | Alessandro Zorzi | Martina Perazzolo Marra | Manuel De Lazzari | Federico Migliore | Benedetta Giorgi | Cristina Basso | Gaetano Thiene | Domenico Corrado | M. Perazzolo Marra | F. Corbetti | A. Zorzi | F. Migliore | Filippo Zilio | Chiara Calore | Giulia Vettor | Luisa Cacciavillani | Francesco Corbetti | C. Calore | M. De Lazzari | F. Zilio | L. Cacciavillani | G. Vettor | Benedetta Giorgi
[1] Roger B. Davis,et al. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.
[2] M. Emdin,et al. Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. , 2012, International journal of cardiology.
[3] O. Simonetti,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.
[4] P R Ershler,et al. Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. , 1993, The Journal of clinical investigation.
[5] Igor Klem,et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation , 2011, Journal of the American College of Cardiology.
[6] Wojciech Zareba,et al. Risk Stratification for Arrhythmic Sudden Cardiac Death: Identifying the Roadblocks , 2011, Circulation.
[7] B. McManus,et al. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. , 1987, The American journal of cardiology.
[8] H. Katus,et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy , 2010, Heart.
[9] Katherine C. Wu,et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[10] A H Harken,et al. Recurrent sustained ventricular tachycardia: structure and ultrastructure of subendocardial regions in which tachycardia originates. , 1983, Circulation.
[11] B. Vandermeer,et al. Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction , 2007, Annals of Internal Medicine.
[12] Katja Zeppenfeld,et al. Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator , 2009, Circulation. Cardiovascular imaging.
[13] Pierre Croisille,et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.
[14] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[15] Maria Drangova,et al. Prediction of Arrhythmic Events in Ischemic and Dilated Cardiomyopathy Patients Referred for Implantable Cardiac Defibrillator: Evaluation of Multiple Scar Quantification Measures for Late Gadolinium Enhancement Magnetic Resonance Imaging , 2012, Circulation. Cardiovascular imaging.
[16] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.
[17] W. Saliba,et al. Role of CMR imaging in risk stratification for sudden cardiac death. , 2013, JACC. Cardiovascular imaging.
[18] Rod Passman,et al. Predicting the future: risk stratification for sudden cardiac death in patients with left ventricular dysfunction. , 2012, Circulation.
[19] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .
[20] P. Kistler,et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. , 2011, Journal of the American College of Cardiology.
[21] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.
[22] Zhilin Qu,et al. Cardiac fibrosis and arrhythmogenesis: the road to repair is paved with perils. , 2014, Journal of molecular and cellular cardiology.
[23] Barry J Maron,et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.
[24] Dan W Rettmann,et al. Accurate and Objective Infarct Sizing by Contrast-enhanced Magnetic Resonance Imaging in a Canine Myocardial Infarction Model , 2022 .
[25] W. Roberts,et al. Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.
[26] R H Hruban,et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.
[27] Claudia Stöllberger,et al. Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.
[28] W. Stevenson,et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[29] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[30] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[31] S. Pogwizd,et al. Mechanisms Underlying Spontaneous and Induced Ventricular Arrhythmias in Patients With Idiopathic Dilated Cardiomyopathy , 1996 .
[32] D. Couri,et al. Cardiovascular Magnetic Resonance in Myocarditis , 2012 .
[33] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[34] M. Fishbein,et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. , 1998, Journal of the American College of Cardiology.